REFERENCES:
1. S. Mukherjee, S. Ray, and R. S. Thakur. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Ind. J. Pharm Sci 2009 Jul;71 (4):349-358.
2. Mudshinge, S.R., Deore, A.B., Patil, S., Bhalgat, C.M. Nanoparticles: emerging carriers for drug delivery. Saudi Pharm. J. 2011; 19, 129–141.
3. Iqbal, M.A., Md, S., Sahni, J.K., Baboota, S., Dang, S., Ali, J. Nanostructured lipid carriers system: recent advances in drug delivery. J. Drug Target. 2012 Dec; 20(10):813-30
4. Basavaraj, K. Nanotechnology in medicine and relevance to dermatology: present concepts. Indian J. Dermatol. 2012.57 (3), 169-174.
5. M. R. Mozafari, Nanocarrier Technologies: Frontiers of Nanotherapy. Springer, 2006; ISBN:1-4020-5040-2, 41-50.
6. Houli Li et.al, Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles, Lou. J. Cont. Release, 2009; 133, 238-244.
7. Melike Uner, Gulgun Yener, Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomedicine, 2007; 2(3), 289-300.
8. Harde, H., Das, M., Jain, S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin. Drug Deliv. 2011 Nov; 8(11): 1407-24.
9. Kayser, O., Lemke, A., Hernandez-Trejo, N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr. Pharm. Biotechnol. 2005 6, 3–5.
10. Muèller, R.H., Maèder, K., Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur. J. Pharm. Biopharm. 2000; 50, 161–177.
11. Müller, R., Maassen, S., Schwarz, C., Mehnert, W. Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes. J. Control. Release. 1997; 47, 261–269.
12. Freitas, C., Müller, R. Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 1999; 47, 125–132.
13. Domingo, C., Saurina, J. An overview of the analytical characterization of nanostructured drug delivery systems: towards green and sustainable pharmaceuticals: a review. Anal. Chim. Acta. 2012; 744, 8–22.
14. Pardeshi C. et.al, Solid lipid based nanocarriers: an overview/Nanonosači na bazi čvrstih lipida: pregled. Acta Pharm. 2012; 62, 433–472.
15. Rainer H. Muller, Karsten Mader and Sven Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur. J. Pharm. Biopharm. 2000; 50, 161–177.
16. Wolfgang Mehnart and Karsten Mader, Solid lipid nanoparticles: production, characterization and applications Adv. Drug. Deliv. Rev., 2001 Apr 25;47(2-3):165-96
17. Annette Zur Mehlen, Cora Schwarz and Wolfgang Mehnart, Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism Eur. J. Pharm. Biopharm., 45, 149-155 (1998).
18. Ekambaram, P.; Sathali, A.; Priyanka, K. Solid lipid nanoparticles: A review. Sci. Rev. Chem. Commun. 2012, 2, 80–102.
19. Olbrich, C.; Gessner, A.; Kayser, O.; Muller, R.H. Lipid-drug conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate. J. Drug Target. 2002, 10, 387–396. [CrossRef] [PubMed]
20. Jaspart, S., Piel, G., Delattre, L., Evrard, B., 2005. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications. Expert Opin. Drug Deliv. 2, 75_87.
21. Kovacevic, A., Savic, S., Vuleta, G., Mu¨ ller, R., Keck, C.M., 2011. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int. J. Pharm. 406, 163_172.
22. Manjunath, K., Reddy, J.S., Venkateswarlu, V., 2005. Solid lipid nanoparticles as drug delivery systems. Methods. Find. Exp. Clin. Pharmacol. 27, 127_144.
23. Elena Ugazia, Roberta Cavalli and M. R. Gasco, Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int. J. Pharm., 25 July 2002, Pages 341-344.
24. Indu Pal Kaur, Rohit Bhandari, Swati Bhandari and Kakkur. Potential of solid lipid nanoparticles in brain targeting J. Cont. Rel., 21 April 2008, Pages 97-109.
25. Antonio J. Almeida and Eliana Souto, Solid lipid nanoparticles as a drug delivery system for peptides and proteins Adv. Drug Delivery Rev., 2007 Jul 10;59(6):478-90.
26. S. P. Vyas and R. K. Khar, Controlled Drug Delivery - Concepts and Advances, First Edition, Vallabh Prakashan (2002) pp. 38-50.
27. Joseph Robinson and Vincent H. L. Lee, Controlled Drug Delivery - Fundamentals and Applications, 2nd Edition, 4-33.
28. Rainer H. Muller, Karsten Mader and Sven Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur. J. Pharm. Biopharm. 2000; 50, 161–177.
29. Müller R.H., Lucks J.S. Arzneistoffträger aus festen Lipidteilchen–Feste Lipid Nanosphären (SLN). EP0605497 (1996)
30. Müller R.H., Petersen R.D., Hommoss A., Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliver Rev 2007; 59: 522–530
31. Müller R.H., Souto E.B., Radtke M. Lipid particles on the basis of mixtures of liquid and solid lipids and methods for producing same. EP00/04111 (2000)
32. Olbrich C., Müller R.H., Kayser O. Lipid drug conjugate nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazene aceturate. J Drug Target 2002; 10: 387– 396
33. Müller, R.H. Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates. WO00/67800 (2000)
34. Shah, R.M., Malherbe, F., Eldridge, D., Palombo, E.A., Harding, I.H., 2014. Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique. J. Colloid. Interface Sci. 428, 286_294.
35. Garcıa-Fuentes, M., Torres, D., Alonso, M., 2003. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf. B Biointerfaces 27, 159_168.
36. Sjo¨stro¨m, B., Bergensta°hl, B., Kronberg, B., 1993. A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions.II: influence of the emulsifier, the solvent, and the drug substance. J. Pharm. Sci.82, 584_589.
37. Ekambaram, P., Sathali, A.A.H., Priyanka, K., 2012. Solid lipid nanoparticles: a review. Sci. Rev. Chem. Commun. 2, 80_102.
38. Lv, Q., Yu, A., Xi, Y., Li, H., Song, Z., Cui, J., et al., 2009. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int. J. Pharm. 372, 191_198.
39. Patel, M., 2012. Development, Characterization and Evaluation of Solid Lipid Nanoparticles as a Potential Anticancer Drug Delivery System. University of Toledo.
40. Trotta, M., Debernardi, F., Caputo, O., 2003. Preparation of solid lipid nanoparticles by a solvent emulsification_diffusion technique. Int. J. Pharm. 257, 153_160.
41. Speiser, P., 1986. Lipid Nano Pellets as Drug Carriers for Oral Administration. EP0167825.
42. Naseri, N., Valizadeh, H., Zakeri-Milani, P., 2015. Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv. Pharm. Bull. 5, 305.
43. Shinoda K., Saito H. The stability of O/W type emulsions as a function of temperature and the HLB of emulsifiers: the emulsification by PIT-method. J Colloid Interface Sci 1969; 30: 258–263
44. Huynh N.T., Passirani C., Saulnier P., Benoit J.P. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 2009; 379: 201–209
45. Chirio D., Gallarate M., Peira E., Battaglia L., Serpe L., Trotta M. Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique. J Microencapsul 2011; 28: 537–548
46. Schubert M.A, Müller-Goymann. C.C. Solvent injection as a new approach for manufacturing lipid nanoparticles – evaluation of the method and process parameters. Eur J Pharm Biopharm 2003; 55: 125–131
47. Hu F.Q., Yuan H., Zhang H., Fang M. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm 2002; 239: 121–128
48. Siekmann B, Westesen K. Investigation on solid lipid nanoparticles prepared by precipitation in o/w emulsion. Eur J Pharm Biopharm 1996; 42:104–109
49. Trotta M., Debernardi F., Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 2003; 257:153-160
50. Garcia-Fuentes M., Torres D., Alonso M.J. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Coll Surf B: Biointerf 2003; 27: 159-168
51. Gallarate M., Trotta M., Battaglia L., Chirio D. Preparation of solid lipid nanoparticles from W/O/W emulsions: Preliminary studies on insulin encapsulation. J Microencaps 2009; 26: 394–402
52. Ribeiro Dos Santos I., Richard J., Pech B., Thies C., Benoit J.P. Microencapsulation of protein particles within lipids using a novel supercritical fluid process Int J Pharm 2002; 242: 69–78
53. Berton A., Piel G., Evrard B. Powdered lipid nano and microparticles: production and applications. Recent Pat Drug Deliv Formul 2011; 5: 188-200
54. Byrappa K., Ohara S., Adschiri T. Nanoparticles synthesis using supercritical fluid technology – towards biomedical applications. Adv Drug Deliv Rev 2008; 60: 299-327
55. Salmaso S., Elvassore N., Bertucco A., Caliceti P. Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process. J Pharm Sci 2009; 98: 640-649
56. Vezzù K., Borin D., Bertucco A., Bersani S., Salmaso S., Caliceti P. Production of lipid microparticles containing bioactive molecules functionalised with PEG. J Supercritical Fluids 2010; 54: 328–334
57. Lubary M, Lubary M, de Loos TW, ter Horst JH, Hofland GW. Production of microparticles from milk fat products using the supercritical melt micronization (ScMM) process. J Supercritic Fluid. 2011;8(3):1079–1088. doi: 10.1016/j.supflu.2010.10.010. [CrossRef] [Google Scholar]
58. Weidner E, Knez Ž, Novak Z. Process for preparing particles or powders. 1995. (Patent 95/021688).
59. Weidner E, Knez Ž, Novak Z. Process for preparing particles or powders. 2000. (Patent US6056791).
60. Knez Ž, Weidner E. In: Industrial Chemistry Library. Bertucco A, Vetter G, editor. Amsterdam: Elsevier; 2001. Precipitation of solids with dense gases; pp. 587–611. [Google Scholar]
61. Cocero MJ, Martín A, Mattea F, Varona S. Encapsulation and co-precipitation processes with supercritical fluids: fundamentals and applications. J Supercritic Fluid. 2009;8:546–555.doi: 10.1016/j.supflu.2008.08.015. [CrossRef] [Google Scholar]
62. Alessi P, Cortesi A, Kikic I, Vecchione F. Plasticization of polymers with supercritical carbon dioxide: experimental determination of glass-transition temperatures. J Appl Polym Sci. 2003;8:2189–2193. doi: 10.1002/app.11881. [CrossRef] [Google Scholar]
63. Bertucco A., Caliceti P., Elvassore N. Process for the production of nanoparticles. WO2007028421 (2007)
64. Chattopadhyay P., Shekunov B., Seitzinger J., Huff R. Particles from supercritical fluid extraction of emulsion. WO2004004862 (2004)
65. Charcosset C., Fessi H. Novel method for preparing solid lipid nanoparticles using a membrane reactor. WO2007000531 (2007)
66. Charcosset C., El-Harati A.A., Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release 2005; 108: 112–120
67. Chattopadhyay P., Shekunov B., Yim D., Cipolla D., Boyd B. Farr S. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev 2007; 6: 444–453
68. Iqbal, M.A., Md, S., Sahni, J.K., Baboota, S., Dang, S., Ali, J., 2012. Nanostructured lipid carriers system: recent advances in drug delivery. J. Drug Target. 20, 813–830.
69. Battaglia, L., Trotta, M., Cavalli, R., 2008. Method for the Preparation of Solid Micro and Nanoparticles. WO2008149215.
70. Battaglia, L., Gallarate, M., Cavalli, R., Trotta, M., 2010. Solid lipid nanoparticles produced through a coacervation method. J. Microencapsul. 27, 78_85.
71. Bianco, M., Gallarate, M., Trotta, M., Battaglia, L., 2010. Amphotericin B loaded SLN prepared with the coacervation technique. J. Drug Deliv. Sci. Technol. 20, 187_191.
72. Chirio, D., Gallarate, M., Peira, E., Battaglia, L., Serpe, L., Trotta, M., 2011. Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids Coacervation technique. J. Microencapsul. 28, 537–548.
73. Gallarate, M., Trotta, M., Battaglia, L., Chirio, D., 2010. Cisplatin-loaded SLN produced by coacervation technique. J. Drug Deliv. Sci. Technol. 20, 343–347.
74. El-Harati A.A., Charcosset C., Fessi H. Influence of the formulation for solid lipid nanoparticles prepared with a membrane contactor. Pharm Dev Technol 2006; 11: 153–157
75. Del Curto M.D., Chicco D., D'Antonio M., Ciolli V., Dannan H., D'Urso S., Neuteboom B., Pompili S., Schiesaro S., Esposito P. Lipid microparticles as sustained release system for a GnRH antagonist (Antide). J Control Release 2003; 89: 297-310
76. Del Curto M.D., Chicco D., Esposito P. Lipid microparticles by cryogenic micronization US2004091522 (2004)
77. Killeen M.J. Spray drying and spray congealing of pharmaceuticals. In Encyclopedia of Pharmaceutical Technology. Edited by Swarbrick J. Boylan JC 2000
78. Pilcer G., Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm 2010; 392:1-19
79. Sebti T., Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur J Pharm Biopharm 2006; 63: 51-58
80. Amighi K., Sebti T. Solid lipid particules as pharmaceutically acceptable fillers or carriers for inhalation. WO2006066367 (2006)
81. Trotta M., Cavalli R., Trotta C., Bussano R., Costa L. Electrospray technique for solid lipid-based particle production. Drug Dev Ind Pharm 2010; 36: 431-438
82. Bussano R., Chirio D., Costa L., Turci F., Trotta M. Preparation and characterization of insulin loaded lipid-based microspheres generated by electrospray. J Disper Sci Technol 2011; 32: 1524-1530
83. Rodriguez L., Cavallari C., Motta G. Apparatus and method for preparing solid forms with controlled release of the active ingredient. WO 9603979 (1996)
84. Passerini N., Qi S., Albertini B., Grassi M., Rodriguez L., Craig D.Q. Solid lipid microparticles produced by spray congealing: influence of the atomizer on microparticle characteristics and mathematical modeling of the drug release. J Pharm Sci 2010; 99: 916-931
85. Rodriguez L., Passerini N., Cavallari C., Cini M., Sancin P., Fini A. Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int J Pharm 1999; 183: 133-143
86. Akiyama, Y.; Yoshioka, M.; Horibe, H.; Hirai, S.; Kitamori, N.; Toguchi, H. Novel oral controlled-release microspheres using polyglycerol esters of fatty acids. J. Control. Release 1993, 26, 1–10.
87. Savolainen, M.; Khoo, C.; Glad, H.; Dahlqvist, C.; Juppo, A.M. Evaluation of controlled-release polar lipid microparticles. Int. J. Pharm. 2002, 244, 151–161.
88. Lander, R., Manger, W., Scouloudis, M., Ku, A., Davis, C., Lee, A., 2000. Gaulin homogenization: a mechanistic study. Biotechnol. Prog. 16, 80_85.
89. Mehnert, W., Ma¨der, K., 2001. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47, 165_196.
90. Westesen, K., Siekmann, B., 1997. Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int. J. Pharm. 151, 35_45.
91. Mudshinge, S.R., Deore, A.B., Patil, S., Bhalgat, C.M., 2011. Nanoparticles: emerging carriers for drug delivery. Saudi Pharm. J. 19, 129–141.
92. Mishra, D.K., Dhote, V., Bhatnagar, P., Mishra, P.K., 2012. Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research. Drug Deliv. Transl. Res. 2, 238–253.
93. Refer to the nanotechnology related news reports appearing in the media within this year - http://www.teriin.org/div/Nano_Vol1.pdf, accessed on 6th February 08.
94. Chowdhury N, Regulatory Supervision of Emerging Technologies, Economic and Political Weekly, 18 November 2006.
95. Regulatory Challenges posed by Nanotechnology Developments in India
96. Meyer, E., Heinzelmann, H. Scanning force microsco-py. In: Wiesendanger R, Guntherodt HJ, editors. Scanning tunneling microscopy II, Surface science. New York: Springer Verlag; 1992, pp. 99–149
97. Mukherjee, S., Ray, S., Thakur, R.S. Solid lipid nanoparticles (SLN): A Modern Formulation Approach in Drug Delivery System. Indian Journal of Pharmaceutical Sciences 2009, 71(4): 349-358.
98. Siekmann, B., Westesen, K. Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids and Surf B Biointerfaces 1994, 3: 159-175
99. Pandey, R., Sharma, S., Khuller, G.K. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tubercu-losis, 2005a, 85(5-6): 415-420.
100. Pandey, R., Khuller, G.K. Solid lipid particle-based inhalable sustained drug delivery system against experi-mental tuberculosis. Tuberculosis. 2005b 85(4): 227-234.
101. Luo, Y., Chen, D., Ren, L., Zhao, X., Qin, J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release 2006, 114(1): 53-59.